Jiangxi Synergy Pharmaceutical Co Ltd (300636) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Jiangxi Synergy Pharmaceutical Co Ltd (300636) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥65.40 Million ≈ $9.57 Million USD) by net assets (CN¥2.38 Billion ≈ $347.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300636 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Jiangxi Synergy Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Jiangxi Synergy Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangxi Synergy Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangxi Synergy Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Greene County Bancorp Inc
NASDAQ:GCBC
0.024x
Doright Co.Ltd.
SHE:300950
-0.007x
Suzhou Kelida Bldg &
SHG:603828
0.085x
Beijing Fjr Optoelectronic Technology Co Ltd
SHG:688272
-0.043x
First Bank
NASDAQ:FRBA
0.024x
Shenzhen Prolto Supply Chain Management Co Ltd
SHE:002769
0.059x
Palm Landscape Architecture Co Ltd
SHE:002431
0.097x
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
-0.065x

Annual Cash Flow Conversion Efficiency for Jiangxi Synergy Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Jiangxi Synergy Pharmaceutical Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 300636 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.37 Billion
≈ $346.11 Million
CN¥202.07 Million
≈ $29.57 Million
0.085x -30.84%
2024-12-31 CN¥2.31 Billion
≈ $337.84 Million
CN¥285.19 Million
≈ $41.73 Million
0.124x +67.95%
2023-12-31 CN¥2.23 Billion
≈ $325.80 Million
CN¥163.75 Million
≈ $23.96 Million
0.074x -50.48%
2022-12-31 CN¥1.32 Billion
≈ $193.11 Million
CN¥196.00 Million
≈ $28.68 Million
0.149x +0.43%
2021-12-31 CN¥888.11 Million
≈ $129.96 Million
CN¥131.34 Million
≈ $19.22 Million
0.148x +50.81%
2020-12-31 CN¥816.50 Million
≈ $119.48 Million
CN¥80.07 Million
≈ $11.72 Million
0.098x +344.98%
2019-12-31 CN¥706.31 Million
≈ $103.36 Million
CN¥-28.27 Million
≈ $-4.14 Million
-0.040x -135.16%
2018-12-31 CN¥658.16 Million
≈ $96.31 Million
CN¥74.93 Million
≈ $10.96 Million
0.114x +113.00%
2017-12-31 CN¥637.10 Million
≈ $93.23 Million
CN¥34.05 Million
≈ $4.98 Million
0.053x -73.06%
2016-12-31 CN¥304.66 Million
≈ $44.58 Million
CN¥60.45 Million
≈ $8.85 Million
0.198x -38.38%
2015-12-31 CN¥246.66 Million
≈ $36.09 Million
CN¥79.42 Million
≈ $11.62 Million
0.322x -41.08%
2014-12-31 CN¥118.02 Million
≈ $17.27 Million
CN¥64.50 Million
≈ $9.44 Million
0.547x +198.77%
2013-12-31 CN¥78.82 Million
≈ $11.53 Million
CN¥14.42 Million
≈ $2.11 Million
0.183x +406.36%
2012-12-31 CN¥45.51 Million
≈ $6.66 Million
CN¥-2.72 Million
≈ $-397.62K
-0.060x --

About Jiangxi Synergy Pharmaceutical Co Ltd

SHE:300636 China Drug Manufacturers - Specialty & Generic
Market Cap
$406.20 Million
CN¥2.78 Billion CNY
Market Cap Rank
#13499 Global
#4070 in China
Share Price
CN¥6.61
Change (1 day)
-0.90%
52-Week Range
CN¥6.52 - CN¥9.30
All Time High
CN¥15532.43
About

Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepr… Read more